Literature DB >> 15763435

Effect of troglitazone on the desaturases in a rat model of insulin-resistance induced by a sucrose-rich diet.

M A Montanaro1, Y B Lombardo, M S González, A M Bernasconi, A Chicco, O J Rimoldi, J C Basabe, R R Brenner.   

Abstract

A sucrose-rich diet generates time-dependent metabolic disorders similar to those found in diabetes type 2. After 8 month (mo) this diet evoked in the rat an increase of blood glucose, free fatty acids (FFA) and triacylycerides (TG) without insulin modification, an interruption of liver stearoyl-CoA desaturase-1 (SCD-1) mRNA and activity increase found at 6 mo, and an enhacement of Delta6 and Delta5 desaturase mRNA and Delta6 activity. We found that the administration of troglitazone (TRO), a peroxisome-proliferator-activated receptors gamma (PPAR-gamma) agonist, for 2 mo normalized plasma FFA, TG, and glucose without altering the insulinemia. It depressed liver SCD-1 mRNA in both control and sucrose-fed rats, decreasing the 18:1n-9/18:0 ratio in serum and liver lipids, and eliminated the increasing effect on mRNA and activity of Delta6 and Delta5 desaturases. These findings evidence again that desaturases are not affected through an insulin resistant effect evoked by the sucrose-rich diet and TRO recovers the altered metabolic plasma parameters as it corresponds to a PPAR-gamma agonist, but its effect on hepatic desaturases can not be attributed to a direct action on liver by PPAR-gamma, insulin, and even by an insulin sensitizing mechanism, suggesting it would be evoked indirectly through hepatic PPAR-alpha deactivation induced by the FFA decrease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763435     DOI: 10.1016/j.plefa.2004.11.003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  2 in total

1.  PPARγ agonist-induced alterations in Δ6-desaturase and stearoyl-CoA desaturase 1: Role of MEK/ERK1/2 pathway.

Authors:  Negar Saliani; Masoud Darabi; Bahman Yousefi; Behzad Baradaran; Mahmoud Shekari Khaniani; Maryam Darabi; Maghsod Shaaker; Amir Mehdizadeh; Tahereh Naji; Mehrdad Hashemi
Journal:  World J Hepatol       Date:  2013-04-27

2.  Diabetic encephalopathy: beneficial effects of supplementation with fatty acids ω3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model.

Authors:  Gustavo Tomás Díaz-Gerevini; Alejandro Daín; María Eugenia Pasqualini; Cristina B López; Aldo R Eynard; Gastón Repossi
Journal:  Lipids Health Dis       Date:  2019-02-08       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.